<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-ONRC-12001883</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2012-01-05</date_registration>
      <primary_sponsor>Department of Gastroenterology and Endocrinology, The 452nd Hospital of PLA</primary_sponsor>
      <public_title>Autologous bone marrow stem cells transplantation for diabetes mellitus</public_title>
      <acronym />
      <scientific_title>Autologous bone marrow stem cells transplantation for diabetes  mellitus</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2010-12-17</date_enrolment>
      <type_enrolment />
      <target_size>1:30;2:30;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=7665</url>
      <study_type>Observational study</study_type>
      <study_design>Non randomized control</study_design>
      <phase>I+II (Phase I+Phase II)</phase>
      <hc_freetext>Diabetes mellitus</hc_freetext>
      <i_freetext>1:routine treatment;2:stem cells+routine treatment;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Weiping Wang</firstname>
        <middlename />
        <lastname />
        <address>1 Gongnongyuan Street, Jinjiang District, Chengdu, Sichuan</address>
        <city />
        <country1 />
        <zip>610021</zip>
        <telephone>+86 13408419088</telephone>
        <email>wwp021006@sina.com</email>
        <affiliation>The 452nd Hospital of PLA</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Daijin Ji</firstname>
        <middlename />
        <lastname />
        <address>1 Gongnongyuan Street, Jinjiang District, Chengdu, Sichuan</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13032896171</telephone>
        <email>jidaijin@163.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Diagnosed type 2 diabetes;
2. Sex is not limited;
3. Aged 18-60 years old;
4. BMI 19 to 24kg/m^2;
5. HbA1C&gt;=7.0%;
6. Signed informed consent.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>60</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Combined serious cardio-cerebrovascular;
2. Liver and kidney function deficiency;
3. Infectious disease;
4. Hematological Diseases;
5. Autoimmune disease;
6. Malignant tumor;
7. Psychotic patients;
8. Allergy to the contrast media.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>HbA1C;C-peptide;Tumor marker;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>BMI;Urine albumin/urine creatinin;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sichuan Province Department of Health (100192)</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2010-04-30</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>